Cardiac magnetic resonance imaging of rapid VCAM-1 up-regulation in myocardial ischemia–reperfusion injury
暂无分享,去创建一个
S. Grieve | G. Figtree | P. Kuchel | A. Gill | T. Tan | R. Bhindi | J. Lønborg | Chia-Chi Liu | W. Lay | J. Mazhar | Edwin Ho
[1] I. Y. Chen,et al. Cardiovascular molecular imaging: focus on clinical translation. , 2011, Circulation.
[2] A. Dart,et al. Evidence for an Acute Diffuse Fibrotic Response Throughout the Left Ventricle Following Acute Myocardial Infarction , 2011 .
[3] Jurgen E. Schneider,et al. In Vivo Quantification of Vcam-1 Expression in Renal Ischemia Reperfusion Injury Using Non-Invasive Magnetic Resonance Molecular Imaging , 2010, PloS one.
[4] K. J. Brooks,et al. Molecular Magnetic Resonance Imaging of Acute Vascular Cell Adhesion Molecule-1 Expression in a Mouse Model of Cerebral Ischemia , 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[5] R. Choudhury,et al. An approach to molecular imaging of atherosclerosis, thrombosis, and vascular inflammation using microparticles of iron oxide☆ , 2010, Atherosclerosis.
[6] G. Dai,et al. Molecular MRI Detects Low Levels of Cardiomyocyte Apoptosis in a Transgenic Model of Chronic Heart Failure , 2009, Circulation. Cardiovascular imaging.
[7] G. Dai,et al. Abstract 593: Molecular MRI of Cardiomyocyte Apoptosis With Simultaneous Delayed Enhancement MRI Distinguishes Apoptotic and Necrotic Myocytes in vivo: Potential for Midmyocardial Salvage in Acute Ischemia , 2009 .
[8] Robin P Choudhury,et al. Molecular imaging in atherosclerosis, thrombosis, and vascular inflammation. , 2009, Arteriosclerosis, thrombosis, and vascular biology.
[9] M. Olschewski,et al. Magnetic Resonance Imaging Contrast Agent Targeted Toward Activated Platelets Allows In Vivo Detection of Thrombosis and Monitoring of Thrombolysis , 2008, Circulation.
[10] S. Neubauer,et al. Visualization of Activated Platelets by Targeted Magnetic Resonance Imaging Utilizing Conformation-Specific Antibodies against Glycoprotein IIb/IIIa , 2008, Journal of Vascular Research.
[11] P. Libby,et al. Activatable Magnetic Resonance Imaging Agent Reports Myeloperoxidase Activity in Healing Infarcts and Noninvasively Detects the Antiinflammatory Effects of Atorvastatin on Ischemia-Reperfusion Injury , 2008, Circulation.
[12] J. Hennig,et al. Functionalized Magnetic Resonance Contrast Agent Selectively Binds to Glycoprotein IIb/IIIa on Activated Human Platelets under Flow Conditions and Is Detectable at Clinically Relevant Field Strengths , 2008, Molecular imaging.
[13] S. Neubauer,et al. Magnetic Resonance Imaging of Endothelial Adhesion Molecules in Mouse Atherosclerosis Using Dual-Targeted Microparticles of Iron Oxide , 2007, Arteriosclerosis, thrombosis, and vascular biology.
[14] Jurgen E Schneider,et al. In vivo magnetic resonance imaging of acute brain inflammation using microparticles of iron oxide , 2007, Nature Medicine.
[15] A. Gabrielsen,et al. Gene expression signals involved in ischemic injury, extracellular matrix composition and fibrosis defined by global mRNA profiling of the human left ventricular myocardium. , 2007, Journal of molecular and cellular cardiology.
[16] Ralph Weissleder,et al. Noninvasive Vascular Cell Adhesion Molecule-1 Imaging Identifies Inflammatory Activation of Cells in Atherosclerosis , 2006, Circulation.
[17] H. Fessi,et al. Preparation, characterization and surface study of poly-epsilon caprolactone magnetic microparticles. , 2006, Journal of colloid and interface science.
[18] C. Bode,et al. Conformation-Specific Blockade of the Integrin GPIIb/IIIa: A Novel Antiplatelet Strategy That Selectively Targets Activated Platelets , 2006, Circulation research.
[19] L. Khachigian,et al. DNAzymes targeting the transcription factor Egr‐1 reduce myocardial infarct size following ischemia–reperfusion in rats , 2006, Journal of thrombosis and haemostasis : JTH.
[20] Donghua Zhu,et al. Biocompatible nanotemplate-engineered nanoparticles containing gadolinium: stability and relaxivity of a potential MRI contrast agent. , 2006, Journal of nanoscience and nanotechnology.
[21] Ralph Weissleder,et al. Nanoparticle imaging of integrins on tumor cells. , 2006, Neoplasia.
[22] J. Foote,et al. Immunogenicity of engineered antibodies. , 2005, Methods.
[23] K. Leong,et al. MR imaging of biodegradable polymeric microparticles: A potential method of monitoring local drug delivery , 2005, Magnetic resonance in medicine.
[24] F. Ramires,et al. Activation of nuclear factor-kappaB and its proinflammatory mediator cascade in the infarcted rat heart. , 2004, Biochemical and biophysical research communications.
[25] R. Kloner,et al. Cardiac protection during acute myocardial infarction: where do we stand in 2004? , 2004, Journal of the American College of Cardiology.
[26] J. Gore,et al. Six-month outcomes in a multinational registry of patients hospitalized with an acute coronary syndrome (the Global Registry of Acute Coronary Events [GRACE]). , 2004, The American journal of cardiology.
[27] Aliasger K Salem,et al. Leukocyte-inspired biodegradable particles that selectively and avidly adhere to inflamed endothelium in vitro and in vivo , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[28] Samuel A. Wickline,et al. Molecular Imaging of Angiogenesis in Early-Stage Atherosclerosis With &agr;v&bgr;3-Integrin–Targeted Nanoparticles , 2003 .
[29] J. Boura,et al. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction : a quantitative review of 23 randomised trials , 2022 .
[30] Shelton D Caruthers,et al. Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v)beta3-integrin-targeted nanoparticles. , 2003, Circulation.
[31] L. Rydén,et al. Pharmacological possibilities for protection against myocardial reperfusion injury. , 2002, Cardiovascular research.
[32] Z. Ding,et al. Role of &agr;4 Integrin and VCAM-1 in CD18-Independent Neutrophil Migration Across Mouse Cardiac Endothelium , 2002, Circulation research.
[33] G. Ambrosio,et al. Reperfusion injury: experimental evidence and clinical implications. , 1999, American heart journal.
[34] A. M. Lefer,et al. Recombinant soluble P-selectin glycoprotein ligand-1 protects against myocardial ischemic reperfusion injury in cats. , 1999, Cardiovascular research.
[35] Hiroki Sato,et al. Monoclonal antibody to ICAM‐1 preserves postischemic blood flow and reduces infarct size after ischemia‐reperfusion in rabbit , 1997, Journal of leukocyte biology.
[36] M. Entman,et al. Postreperfusion inflammation: a model for reaction to injury in cardiovascular disease. , 1994, Cardiovascular research.
[37] T. Carlos,et al. Vascular cell adhesion molecule-1 mediates lymphocyte adherence to cytokine-activated cultured human endothelial cells. , 1990, Blood.
[38] L. Becker,et al. Neutrophil depletion limited to reperfusion reduces myocardial infarct size after 90 minutes of ischemia. Evidence for neutrophil-mediated reperfusion injury. , 1989, Circulation.
[39] A. Ericsson,et al. Relaxation Enhancement of the Dog Liver and Spleen by Biodegradable Superparamagnetic Particles in Proton Magnetic Resonance Imaging , 1987, Acta radiologica.
[40] S. Kunkel,et al. Reduction of myocardial infarct size by neutrophil depletion: effect of duration of occlusion. , 1986, American heart journal.